Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global DNA Extraction Kits Market - Outlook and Forecast 2022-2027
The DNA extraction kit market, valued at USD 1.3 billion in 2021, is projected to reach USD 2.1 billion by 2027, with a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2022-2027.
DNA is at the center of the genomic revolution and its associated IT infrastructure. Its impact on the healthcare sector is significant, particularly in faster cancer detection, potentially saving numerous lives worldwide. Genomic innovations based on DNA have progressed from gene editing to the development of anti-cancer drugs. DNA is widely used as an initial sample for various diagnostic and research purposes. While DNA extraction is a complex process, the introduction of DNA extraction kits has simplified the procedure, making it more efficient. The extracted DNA is primarily utilized to study the genetic causes of diseases, carry out forensic sciences, develop drugs and personalized medicines, conduct paternity tests, and perform genome sequencing. Furthermore, genomic advancements are playing a major role in agricultural biology, contributing significantly to plant breeding technology and research aimed at reducing crop production costs, among other areas.
|No. of Pages||
USD 1.4 billion in 2020
Product Type, Application, Sample Type, End-User, and Geography
|No. of Companies Mentioned||
One notable advantage is the availability of RNA/DNA extraction kits in various product types for multiple sample types. These include kits specifically designed for extracting microbial DNA (such as viruses and bacteria), tissue samples, forensic DNA, cell-free DNA, and more. This diverse product portfolio has contributed to the growing number of end-users in the DNA extraction kit market.
Technological advancements are expected to drive the growth of the RNA/DNA extraction kit market. The increasing demand for RNA/DNA extraction kits stems from their broad range of applications, including PCR, genome sequencing, cloning, and others. The rise in demand for these applications will fuel the growth of the DNA extraction kit market. For instance, the introduction of next-generation DNA extraction kits, equipped with optimized protocols, enables users to isolate genomic DNA from various samples, yielding high-quality DNA even from specialized samples. Researchers widely adopt these kits for their multipurpose research needs.
The use of next-generation sequencing (NGS) is on the rise in cancer research and personalized treatments. DNA extraction serves as a fundamental step in NGS library preparation. The growing demand for personalized medicine, CAR-T therapies, gene therapies, and other regenerative medicines is driving the increased usage of DNA extraction kits in the market. Additionally, the presence of numerous research institutes and standalone genomic labs in developed countries like the US, the UK, and Germany, which are actively involved in genetic research, genome sequencing, and the study of diseased genes in cancer and neurological disorders, among other rare genetic diseases, contributes significantly to the adoption of DNA isolation kits.
The COVID-19 pandemic had a negative impact on the market. Focused efforts were directed towards RNA extraction kits, subsequently reducing the usage of DNA extraction kits. Additionally, fewer products were launched during the pandemic as many genomic research centers shifted their focus to sequencing COVID-19 variants and developing vaccines. This diversion of resources and researchers away from DNA-based research is expected to recover once the COVID-19 pandemic subsides.
The market is segmented based on various factors, including product type, application, sample type, end-user, and geography.
Tissue & FFPE
Pharma & Biotech Companies
Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey
The North America region currently holds the largest market share in the DNA extraction kit market. However, the Asia-Pacific (APAC) region is expected to exhibit faster growth, with a compound annual growth rate (CAGR) of over 9% in the DNA extraction market. This growth can be attributed to increasing investments in genome sequencing, the rising adoption of genetic testing-based diagnostics for rare diseases and oncology, as well as the higher adoption of personalized medicines, which are driving the North American market.
In terms of end-users, healthcare facilities with in-house laboratories dominate this segment. The increasing number of samples tested for various genetic diseases and oncology is a major driving force for the healthcare segment’s use of DNA extraction kits.
When it comes to sample types, blood, tissue, and FFPE (Formalin-Fixed Paraffin-Embedded) samples are the dominant types in the market. Blood and tissue-based samples are primarily used in the diagnostic segment, while FFPE samples, which are preserved for biopsies, experimental research, diagnostics, and drug development, contribute significantly to the volume of samples that require DNA extraction. These sample types play a crucial role in the DNA extraction kit market.
In terms of product types, cell-free DNA accounts for a significant portion of the market. However, the genomic DNA segment is experiencing rapid growth due to increased investments in genomic research and personalized medicines. The genomic DNA segment is expected to grow at a CAGR of 8.01% in the market.
Regarding applications, the PCR (Polymerase Chain Reaction) application dominates the segment. PCR is considered the gold standard method for DNA extraction in various study purposes and diagnostics. The sequencing application is also witnessing significant growth, driven by technological advancements focused on genomic diagnostics.
The global market for DNA extraction kits is highly competitive and is anticipated to undergo significant changes due to advancements in technology. Key industry players, including Agilent Technologies, Bio-Rad Laboratories, Roche, Promega, QIAGEN, and Thermo Fisher Scientific, currently hold substantial market shares. However, these established companies face strong competition from emerging players in the market.
Key companies profiled in this report include Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, Promega, QIAGEN, Thermo Fisher Scientific, 1st BASE, 3B BlackBio Biotech India, BioChain Institute, Bioneer, BLIRT, Canvax, Cell Projects, Covaris, Cytiva, Fivephoton Biochemicals, Galenvs Sciences, Geneaid Biotech, IBI Scientific, INVITEK Molecular, LabTurbo, Lexogen, LGC Biosearch Technologies, Lucigen, MagGenome, Merck, MP BIOMEDICALS, New England Biolabs, Omega Bio-tek, PCR Biosystems, PerkinElmer, Primerdesign, Takara Bio, Vivantis Technologies, Xi’an Tianlong Science and Technology, Zymo Research.
Key Questions Answered
What is the projected size of the global RNA/DNA extraction kit market by 2027?
By 2027, the DNA extraction kit market is expected to reach a size of USD 2.1 billion, with a compound annual growth rate (CAGR) of 7.7%.
Who are the major players in the DNA extraction kit industry?
Some of the key players in the DNA extraction industry include Agilent Technologies, Promega, Bio-Rad Laboratories, and Qiagen.
Which region holds the largest market share in the global RNA/DNA extraction kit market?
North America holds the highest market share in the global DNA extraction kit market.
What are the latest trends observed in the market?
The latest trends in the market include the introduction of next-generation DNA extraction kits that offer faster and more efficient DNA sample yields. There is also an increasing demand for genome projects, genetically engineered plants, and personalized medicines.
What factors are influencing the growth of the DNA extraction kit market?
Factors influencing the growth of the DNA extraction kit market include the wide range of applications such as genome sequencing, the rise in genetic diagnostics, an increase in rare genetic disorders, and the growing field of molecular diagnostics.